Search Results - "Arslandemir, C"

Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer by Schirrmeister, H, Glatting, G, Hetzel, J, Nüssle, K, Arslandemir, C, Buck, A K, Dziuk, K, Gabelmann, A, Reske, S N, Hetzel, M

“…Previous studies have shown that vertebral bone metastases (BM) not seen on planar bone scintigraphy (BS) might be present on (18)F-fluoride PET scans or at…”
Get full text

F‐18 NaF PET for Detection of Bone Metastases in Lung Cancer: Accuracy, Cost‐Effectiveness, and Impact on Patient Management by Hetzel, Martin, Arslandemir, Coskun, König, Hans‐Helmut, Buck, Andreas K, Nüssle, Karin, Glatting, Gerhard, Gabelmann, Andreas, Hetzel, JÜRgen, Hombach, Vinzenz, Schirrmeister, Holger

“…As bone metastases might be present in lung cancer despite a normal bone scan, we examined various alternatives prospectively. Positron emission tomography…”
Get full text

Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study by Hetzel, Martin, Hetzel, Juergen, Arslandemir, Coskun, Nüssle, Karin, Schirrmeister, Holger

“…Introduction Based on the hypotheses that most skeletal metastases in lung cancer are clinically symptomatic, that the incidence of bony metastases in early…”
Get full text

Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer by Schirrmeister, Holger, Arslandemir, Coskun, Glatting, Gerhard, Mayer-Steinacker, Regine, Bommer, Martin, Dreinhöfer, Karsten, Buck, Andreas, Hetzel, Martin

“…The leading European and American professional societies recommend that bone scans (BS) should be performed in the staging of lung cancer only in those…”
Get full text